Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene

Chest

Volumn 122, Issue 1, 2002, Pages 171-176

  Lee, Sang Yeub ^a   Lee, Young Ho ^a   Shin, Chol ^a   Shim, Jae Jeong ^a   Kang, Kyung Ho ^a   Yoo, Se Hwa ^a   In, Kwang Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Asthma; Bronchial hyperresponsiveness; Cytotoxic T lymphocyte antigen 4 polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E;

ACCESSORY CELL; ADULT; AGED; ALLELE; ARTICLE; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HELPER CELL; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

EID: 0036305402     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.1.171     Document Type: Article

References (27)

1. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway responsiveness
2. The costimulatory function of antigen-presenting cells
3. Costimulation of T lymphocytes: The role of CD28, CTLA- 4 and B7/BB1 in interleukin-2 production and immunotherapy
4. Molecules involved in T-cell co-stimulation
5. The role of cell division in the induction of clonal anergy
6. B7-CD28/ CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens
7. Immunoregulatory networks in asthma
8. The role of co-stimulation in airway inflammation
9. CTLA-4 engagement inhibits accumulation and cell cycle progression upon activation of resting T cell
10. CTLA-4 ligation blocks CD28-dependent T cell activation
11. The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes
12. Dinucleotide repeat polymorphism at the human CTLA4 gene
13. An MseI RFLP in the human CTLA-4 promoter
14. Standards for the diagnosis and care of patients with chronic obstuctive pulmonary disease (COPD) and asthma: This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986
15. CTLA4 gene polymorphism confers susceptibility to Graves’ disease in Japanese
16. The codon 17 polymorphism of the CTLA4 gene in type 2 diabetes mellitus
17. CTLA-4 alanine-17 confers genetic susceptibility to Graves’ disease and to type 1 diabetes mellitus
18. CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis
19. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis
20. CTLA4 promoter and exon 1 dimorphism in multiple sclerosis
21. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders
22. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma
23. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma
24. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation
25. The R576 IL-4 receptor alpha allele correlates with asthma severity
26. Pulmonary function testing